Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01792960

Enrollment

Registered

2013-02-15

Start date

2013-02-28

Completion date

2013-08-31

Last updated

2014-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Familial Hypertrophic Cardiomyopathy

Brief summary

Set the Korean Familial Hypertrophic Cardiomyopathy (KFHC) registry to study the prevalence of gene mutations in Korean patients with familial hypertrophic cardiomyopathy

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

13 Years to No maximum

Healthy volunteers

Inclusion criteria

1. left ventricular maximal wall thickness ≥ 15mm on echocardiography 2. hypertrophic cardiomyopathy patients' relatives

Exclusion criteria

1. other cardiomyopathy or systemic disease (e.g. fabry disease, danon disease, glycogen storage disease) 2. who deny the study entrance, especially in patients' relatives

Design outcomes

Primary

Measure	Time frame	Description
1) DNA analysis	1 year	1\) Identify susceptible genes for familial hypertrophic cardiomyopathy in Korean

Secondary

Measure	Time frame	Description
2) Prognosis of familial hypertrophic cariomyopathy	1 year	2\) all-cause mortality, hospitalization for heart failure progression, stroke, heart transplantation

Countries

South Korea

Outcome results